D.E. Shaw & Co’s Cidara Therapeutics CDTX Stock Holding History

D.E. Shaw & Co’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,109	Closed	-$466K	–	4591
2025 Q4	$466K	Sell	2,109 -36,724	-95%	-$5.94M	﹤0.01%	3961
2025 Q3	$3.72M	Buy	+38,833	New	+$2.48M	﹤0.01%	2475

D.E. Shaw & Co's CDTX Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 2,109 shares — an estimated $466K sold.

D.E. Shaw & Co first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $3.72M in Q3 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

D.E. Shaw & Co reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
D.E. Shaw & Co sold 2,109 Cidara Therapeutics shares in Q1 2026, an estimated $466K.
D.E. Shaw & Co first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
D.E. Shaw & Co's Cidara Therapeutics position peaked at $3.72M in Q3 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.